Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant adverse » significant advantage (Expand Search)
significant event » significant effect (Expand Search), significant level (Expand Search), significant effects (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant adverse » significant advantage (Expand Search)
significant event » significant effect (Expand Search), significant level (Expand Search), significant effects (Expand Search)
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
Baseline demographics and comorbidities by presence of post-treatment adverse cardiovascular events.
Published 2024Subjects: -
11
Cox regression models for adverse cardiovascular events (ACE) and individual components of ACE.
Published 2024Subjects: -
12
-
13
Presentation 1_Prehospital tranexamic acid decreases early mortality in trauma patients: a systematic review and meta-analysis.pdf
Published 2025“…</p>Conclusion<p>Prehospital TXA decreases early (24-h) mortality in trauma patients without a significant increase in the risk of VTE and other complications, and further studies are still needed to improve and optimize its management strategy.…”
-
14
Data Sheet 1_Prehospital tranexamic acid decreases early mortality in trauma patients: a systematic review and meta-analysis.docx
Published 2025“…</p>Conclusion<p>Prehospital TXA decreases early (24-h) mortality in trauma patients without a significant increase in the risk of VTE and other complications, and further studies are still needed to improve and optimize its management strategy.…”
-
15
-
16
Number of adverse reaction case reports of finasteride administration at the PT level.
Published 2025Subjects: -
17
-
18
-
19
Adverse event list.
Published 2025“…</p><p>Non-motor symptoms of PD, motor parkinsonian signs off medication, and quality of life improved significantly during the treatment phase, including the MDS-UPDRS total score (mean decrease −11.09; 95% Confidence Interval [CI]; −18, −4.1; <i>p</i> = 0.006), the Parkinson’s disease Questionnaire-39 (PDQ-39) summary index (mean decrease −2.91; 95% CI; −4.4, −1.4; <i>p</i> = 0.005), and the Non-Motor Symptoms Questionnaire (NMS-Quest) (mean decrease −4.27; 95% CI; −6.5, −2.1; <i>p</i> = 0.009). …”
-
20